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Hydrolyzed wheat protein (HWP) is made from gluten by acid or
enzymemodiﬁcation and used formany cosmetics around theworld.
Recently, reports emerged about 2169 patients with wheat allergy
sensitized to HWP in facial soap (HWP-wheat allergy) and conse-
quently represented in an important social problem in Japan.1e3
Most patients had used the same soap bar named “Cha-no-Shi-
zuku™” containing HWP. HWPused in “Cha-no-Shizuku™”wasGlu-
pearl19S.Although itwasalsocontained inseveralother typesof soap
bars, all of themhad alreadybeen recalled.Most of the patients sensi-
tized to HWPwere female and their peak agewas in the 40s.3 Several
severe cases led toanaphylaxis. 56%and16%of thepatientsdeveloped
symptoms after exercise or oral intake of NSAIDs, respectively.
Although serumwheat- and gluten-speciﬁc IgE are negative and
u-5 gliadin-speciﬁc IgE is positive in CAP-FEIA (CAP-ﬂuoro enzyme
immune assay) in most patients with conventional wheat-
dependent exercise-induced anaphylaxis (WDEIA),4 wheat- and
gluten-speciﬁc IgE are positive and u-5 gliadin-speciﬁc IgE is nega-
tive in many patients with HWP-wheat allergy, even in the WDEIA
subtype.3,5 Moreover, patients with HWP-wheat allergy exhibit
positive skin prick tests and basophil histamine release tests
(HRT) against HWP, Glupearl 19S. Those positive reactions against
HWP are speciﬁc to patients with HWP-wheat allergy.5
Wepreviously reporteda remissioncaseofHWP-wheatallergyaf-
ter cessation of HWP-containing soap6 and also reported that hyper-
sensitivities againstwheat componentsweremostly reduced in those
patients.5 However, substantial numbers of patients still avoid food
containingwheat, and the remission rate and/or change of hypersen-
sitivityagainstHWPofoverall patientshavenot yetbeendetermined.
Here, we investigated clinical remission rate of HWP-wheat allergy
and negative conversion rate of ex vivo HRT against HWP.
We retrospectively studied 110 patients who were diagnosed
with HWP-wheat allergy, visited Hiroshima University Hospital
from January 2010 to December 2013, and who were followed until
September 2014. Patients were diagnosed according to the criteria
for immediate wheat allergy to the hydrolyzed wheat (Glupearl
19S) contained in “Cha-no-Shizuku” soap and some other products
by the Special Committee for the Safety of Protein Hydrolysate in
Cosmetics (Supplementary Table 1).7 The remission rate of HWP-
wheat allergy and the negative conversion rate of HRT against
HWPwere analyzed by KaplaneMeier methods, and related factors
were analyzed by the log-rank test. We deﬁned “Remission” as con-
dition free of symptoms for more than 3 months without anyPeer review under responsibility of Japanese Society of Allergology.
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% histamine release against HWP (Glupearl 19S) was less than 5%
as described previously.5
The mean age ± SD of the patients was 44.3 ± 15.3 years old and
most patients (94.5%) were female (Supplementary Table 2). We
divided the patients into 3 types: WDEIA, exercise independent,
and contact urticaria. Ninety-two patients were WDEIA type.
They were relatively younger than patients of the other groups.
We conﬁrmed remission in 20 patients with WDEIA type and con-
tact urticaria type. In contrast, none of the patients with exercise in-
dependent type reached remission. Eight patients were excluded
from the analysis of remission rate, since their time points of
discontinuation of the soap were indeterminate. Basophil reactiv-
ities against HWP were followed in 58 out of 110 patients. Mean
follow-up period ± SD from cessation of soap usage to remission
or drop out, and mean follow-up period ± SD from cessation of
soap usage to negative conversion of HRT against HWP were
26.5 ± 16.2 and 27.3 ± 15.7 months, respectively.
The median duration from stop usage of soap to remission was
59.8 months. The negative conversion rates of HRT against HWP in
early 24months appears to be less than remission rate, but the pre-
cise relationship between two parameters are difﬁcult because of a
small size of the subjects especially after 48 months (Fig. 1). We
explored signiﬁcant prognostic factors and found that the remission
rate of the patients under 30-year-old was signiﬁcantly higher than
that of patients 30 years or older (p ¼ 0.0013**) (Table 1). We could
not ﬁnd a signiﬁcant difference among sex, symptoms, period of
soap usage and serum levels of speciﬁc-IgE against nativewheat an-
tigens at the ﬁrst visit (Table 1). We also analyzed the same factors
using the log-rank test, but did not ﬁnd any factors related to nega-
tive conversion rates of HRT against HWP (Supplementary Table 3).
In this study, we investigated the remission rate and the negative
conversion rate of HRTagainst HWP in patients with HWP-wheat al-
lergy. As reportedpreviously,mostpatients in this studyweremiddle
aged women and WDEIA type was the most frequent among the
three subtypes. The remission rate gradually increased and reached
around50%approximatelyat 5 years after cessationofHWP-soapus-
age. This result suggests that HWP-wheat allergy is curable by cessa-
tion of HWP-soap use, and that prognosis of HWP-wheat allergy is
different fromconventionalWDEIA in adults. It is feasible that imme-
diate hypersensitivity due to cutaneous or rhinoconjunctival sensiti-
zation may be cured more quickly by the avoidance of causative
antigens than that caused by sensitization via the gastrointestinal
tract. Latex allergy, another example of cutaneous sensitization, has
also been reported to be reduced in its reactivity byavoidance of nat-
ural rubber latex exposures.8 However, it is noteworthy that mostvier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
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Fig. 1. Remission rate and negative conversion rate of HRT in patients with HWP-wheat allergy. The remission (A) and negative conversion rates of HRT against HWP (B) in patients
with HWP-wheat allergy were estimated by the KaplaneMeier method.
Table 1
Prognostic analysis using the log-rank test.
Number
of patients
Estimated remission rate (%) Median duration until remission
from discontinuation of HWP-soap
(months)
p-Value
12 months 24 months 60 months
Gender Male 5 0 33.3 33.3 Undeﬁned 0.4168
Female 97 2.3 9.9 55.7 59.8
Age <30 years old 18 0 31.6 100 37.8 0.0013**
30 years old 84 2.6 5.7 45.2 60.5
Symptoms Only skin symptoms 35 7.3 11.1 100 59.8 0.5542
With anaphylaxis 24 0 14.9 57.4 51.7
Anaphylactic shock 35 0 7.0 39.4 60.5
Periods of soap usage <2 years 53 4.2 9.7 61.9 59.8 0.8227
2 years 48 0 11.4 43.9 60.5
Serum levels of speciﬁc-IgE Wheat Class 0 30 3.7 13.2 72.9 59.8 0.7509
Class 1 or more 58 0 10.9 27.0 60.5
Gluten Class 0 22 5.3 17.7 45.1 Undeﬁned 0.8289
Class 1 or more 65 0 9.8 58.1 59.8
u-5 gliadin Class 0 80 1.4 12.7 55.3 59.8 0.3231
Class 1 or more 6 0 0 0 Undeﬁned
Analyzed by the log-rank test. **p<0.01.
Letter to the Editor / Allergology International 65 (2016) 109e111110patients who achieved the “remission” deﬁned in this study still
showed positive reaction in skin test for Glupearl 19S (data not
shown). Likewise 9 out of 13 remitted patients were still positive
against Glupearl 19S in HRT (Supplementary Table 4).
Another interesting result of our study is the relationbetweenage
and remission rate. The remission rate of patients under 30-year-old
is statistically higher than for patients aged 30 years or older. Usually,
immediate food allergy such as egg-, milk- and wheat-allergy in
childhood is more easily tolerated than in adults.9,10 This might be
due to a change of immune tolerance with age.
In conclusion, we have conﬁrmed that hypersensitivity against
HWP sensitized by facial soap containing HWP is decreasing and
that HWP-wheat allergy may be clinically cured in many cases.
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